Literature DB >> 14571713

Mirizzi syndrome with cholecysto-choledocal fistula with a high CA19-9 level mimicking biliary malignancies: a case report.

A Principe1, M Del Gaudio, G L Grazi, U Paolucci, A Cavallari.   

Abstract

Mirizzi syndrome type II is a form of obstructive jaundice caused by a stone impacted in the gallbladder neck or the cystic duct that impinges on the common hepatic duct with a cholecysto-choledochal fistula. Preoperative recognition is necessary to prevent injury to the common duct during surgery. We present a patient with an operative diagnosis of type II Mirizzi syndrome, which was not originally indicated in the preoperative work-up; in particular endoscopic retrograde cholangiopancreatography showed stenosis of the middle third of the hepatic duct along with markedly elevated serum CA19-9 levels (up to 35,000 U/mL). Surgical specimen examination did not reveal the presence of neoplasia. We performed cholecystectomy and a jejunal loop was brought up and anastomosed to the common duct at the hilar level in a Roux-en-Y fashion. In cases such as ours with extensive fibrosis and inflamed tissue mimicking cholangiocarcinoma or gallbladder carcinoma, a wide hepaticojejunostomy is required to establish adequate biliary drainage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14571713

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  11 in total

1.  Detection of early-stage extrahepatic cholangiocarcinoma in patients with biliary strictures by soluble B7-H4 in the bile.

Authors:  Wenbo Ke; Li Zeng; Yunbi Hu; Sisi Chen; Min Tian; Qinggang Hu
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma.

Authors:  Kawin Leelawat; Siriluck Narong; Jerasak Wannaprasert; Thawee Ratanashu-ek
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

3.  Mirizzi syndrome.

Authors:  Sushil K Ahlawat; Rohit Singhania; Firas H Al-Kawas
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

4.  Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker.

Authors:  Mao-Song Lin; Jun-Xing Huang; Hong Yu
Journal:  Int J Clin Exp Med       Date:  2014-03-15

5.  Mirizzi syndrome: history, current knowledge and proposal of a simplified classification.

Authors:  Marcelo A Beltrán
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

Review 6.  Surgical treatment of gallbladder carcinoma: a critical review.

Authors:  Farzad Kakaei; Samad Beheshtirouy; Seyed Mohammadreza Nejatollahi; Sina Zarrintan; Mohammad Reza Mafi
Journal:  Updates Surg       Date:  2015-11-12

7.  Elevation of CA 19-9 in Mirizzi Syndrome in the Absence of Malignancy: A Case Report.

Authors:  Leena H Moshref; Rasha Abdulaziz Mandili; Murouj Almaghrabi; Rahaf Abdulrashid Abdulwahab; Rawan A Alosaimy; Jameel Miro
Journal:  Am J Case Rep       Date:  2021-07-01

8.  Mirizzi's syndrome masquerading as cholangiocarcinoma: a case report.

Authors:  Muhammad Rizwan Khan; Sameer Ur Rehman
Journal:  J Med Case Rep       Date:  2012-06-15

9.  Two patients with extremely elevated tumor markers: where is the malignancy?

Authors:  Patrick P J van der Veek; Wouter H de Vos Tot Nederveen Cappel; Alexandra M J Langers; Bart van Hoek
Journal:  Gastroenterol Res Pract       Date:  2011-06-16       Impact factor: 2.260

10.  Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.

Authors:  Kawin Leelawat; Sompong Sakchinabut; Siriluck Narong; Jerasak Wannaprasert
Journal:  BMC Gastroenterol       Date:  2009-04-30       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.